EHPLE Anesthesia study materials
EHPLE Anesthesia study resources

Local Anesthetic Systemic Toxicity During Interscalene Brachial Plexus Block

EHPLE Anesthesia · Put your knowledge to work in context.

All case studies

Local Anesthetic Systemic Toxicity During Interscalene Brachial Plexus Block

A 62-year-old man, 70 kg, is scheduled for right shoulder arthroscopy under general anesthesia with an interscalene brachial plexus block for postoperative analgesia. The patient is otherwise healthy and takes no regular medications. The block is performed with a nerve stimulator after negative aspiration, using 40 mL of ropivacaine 0.5% (200 mg). Three minutes after the injection, he reports tinnitus and a metallic taste, then becomes agitated and has a generalized tonic-clonic seizure. Shortly afterwards, he becomes bradycardic at 38 beats/min and hypotensive at 60/30 mmHg. The airway is secure with a supraglottic airway, and oxygen saturation is 96% on 100% oxygen. The surgeon has not started the procedure. The anesthesia team has 20% lipid emulsion available, but the nearest cardiopulmonary bypass team is 30 minutes away.

1. Calculate the ropivacaine dose in mg/kg and explain why systemic toxicity developed despite an apparently acceptable total dose.

Read the worked answer

Dose calculation:

  • Ropivacaine 0.5% contains 5 mg/mL.
  • 40 mL × 5 mg/mL = 200 mg.
  • 200 mg ÷ 70 kg = 2.86 mg/kg.

Why toxicity occurred:

  • The maximum recommended single dose of ropivacaine is approximately 3 mg/kg, so 2.86 mg/kg is very close to the ceiling. There is little margin for error.
  • The interscalene region is highly vascular. A negative aspiration does not exclude intravascular placement, because the needle tip can move or the vessel can be compressed during aspiration.
  • Absorption from a vascular plexus is rapid, so toxic concentrations can occur within minutes.
  • The patient's symptoms are classic: tinnitus and metallic taste are early central nervous system signs, followed by agitation, seizure, and then cardiovascular toxicity with bradycardia and hypotension.

Reasoning: Ropivacaine is less cardiotoxic than bupivacaine, but it still causes seizures and cardiovascular collapse at high doses. The dose was near the maximum, and the site was high-risk. This is a dose-and-site problem, not necessarily a violation of a arbitrary limit.

2. State the immediate management priorities and the exact lipid emulsion regimen you would use.

Read the worked answer

Immediate priorities:

  1. Stop the injection and call for help.
  2. Maintain the airway and give 100% oxygen; the supraglottic airway is already in place.
  3. Control the seizure with a benzodiazepine, for example midazolam 2–4 mg IV titrated.
  4. Start 20% lipid emulsion immediately.
  5. Treat bradycardia and hypotension with small doses of epinephrine, and start an infusion if needed.

Lipid emulsion regimen:

  • Bolus: 1.5 mL/kg of 20% lipid emulsion = 1.5 × 70 = 105 mL over about 1 minute.
  • Infusion: 0.25 mL/kg/min = 17.5 mL/min, continued for at least 15 minutes after circulatory stability.
  • Repeat the bolus once or twice if the patient remains unstable.
  • Maximum cumulative dose: approximately 10 mL/kg over 30 minutes.

Additional considerations:

  • Avoid lidocaine for arrhythmias.
  • Avoid vasopressin, calcium channel blockers, beta blockers, and large doses of epinephrine.
  • If cardiac arrest occurs, perform prolonged CPR and consider extracorporeal membrane oxygenation; do not stop resuscitation early.

Reasoning: Lipid emulsion acts as a lipid sink and supports myocardial energetics. It must be given early, alongside standard resuscitation, not after other measures fail.

3. What preventive changes would you make for future blocks in this patient?

Read the worked answer

Preventive changes:

  • Use ultrasound guidance in addition to nerve stimulation, because direct visualization reduces but does not eliminate intravascular injection.
  • Inject incrementally, aspirating every 3–5 mL, and monitor the patient continuously during injection.
  • Reduce the total dose: for interscalene block, 20–30 mL of a lower concentration such as ropivacaine 0.375% is often sufficient for analgesia.
  • Avoid using the maximum calculated dose simply because it is below the limit; use the smallest effective volume.
  • Consider adding a perineural adjuvant such as dexamethasone to prolong analgesia and allow a lower local anesthetic dose.
  • Have lipid emulsion immediately available wherever high-volume blocks are performed.
  • Monitor the patient with continuous ECG, pulse oximetry, and blood pressure during and after injection.

Reasoning: The event was likely caused by a combination of a near-maximum dose and a highly vascular injection site. Reducing volume and concentration, injecting slowly under ultrasound, and monitoring for early symptoms are the most reliable safeguards.